Pharmaceutical Sponsors | Mary Crowley Cancer Research

PHARMACEUTICAL COLLABORATORS

About Mary Crowley Cancer Research

Mary Crowley Cancer Research (MCCR) is an independent, nonprofit oncology research center established in 1997. Founded by Mary C. Crowley, our mission is to bring hope to cancer patients through innovative clinical trials while advancing treatment for patients in the future.

MCCR has conducted 740+ clinical trials for 7400+ patients in collaboration with 291+ different pharmaceutical partners. MCCR is designed, equipped, and staffed for conducting early phase solid tumor and hematology trials, including performing 129+ first-in-human trials. Outpatient and inpatient hospital support, and a dedicated referral and consult team. MCCR has completed phase I and phase II, industry funded studies including first-in-human, drug-drug interaction, food effect, bioequivalence, and intensive EKG monitoring studies. This site has experience using gene therapies, cytokines, cytotoxic agents, cellular therapies, small molecules, viral therapies, monoclonal antibodies, antibody drug conjugates, immune therapy, and vaccines.

An Accelerated Approach to Cancer Research

Study Start-Up	Patient Population	Data
8 - 10 weeks from receipt of final protocol - may be shorter under our Just-in-Time (JIT) program Parallel completion of all startup activities Prompt review/approval - local Institutional Review Board meets weekly	Referral base of over 420 oncologists Robust Molecular Registry - reportable for rapid enrollment Outreach team focused on educating community oncologists of trials and their technology	70/70 Successful MQA Audits 6/6 Successful FDA Audits Data team located within clinic to expedite data entry timelines

The Clinic

State-of-the-Art, 14,000 square foot clinic located on the campus of Medical City Hospital, Dallas.
Dedicated research clinical staff (CRNs, CRC, PharmD, and supporting personnel)
13 infusion chairs
Integrated research-only pharmacy
BSL II compliant isolation rooms
Specialized laboratory processing (including PBMCs)

The Administrative Offices

16,000 square foot administrative office space
Dedicated research employees (Finance, Legal, Project Management, Regulatory, IRB, Marketing/Business Development, Leadership)
Monitoring suites with high-speed internet access

Processes

Click below to access an overview of our site’s processes (pdf)

Clinical and Administrative Processes

Jan. 31, 2022

FOR MORE INFORMATION, CONTACT:

Alisha Doege, Study Development Manager, and Tina Nghiem, Associate Director, Clinical Trial Development, at pharma@marycrowley.org